• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.

作者信息

Hasselbalch H, Jensen B A

机构信息

Department of Medicine and Haematology C, Gentofte University Hospital, Denmark.

出版信息

Eur J Haematol. 1990 Mar;44(3):172-8. doi: 10.1111/j.1600-0609.1990.tb00372.x.

DOI:10.1111/j.1600-0609.1990.tb00372.x
PMID:2328790
Abstract

In a prognostic univariate analysis of a series of 80 patients with idiopathic myelofibrosis the Hb-concentration, the platelet count and osteomyelosclerosis emerged as factors with prognostic significance. A Hb-concentration less than 10 g/dl was associated with a significantly shorter survival than a Hb-concentration greater than or equal to 10 g/dl. A platelet count less than 100 x 10(9)/l also implied a significantly shorter survival. Patients with osteomyelosclerosis on X-ray of the skeleton had a significantly better prognosis as compared to those without osteomyelosclerosis. In a multivariate regression analysis the Hb-concentration consistently emerged as an important prognostic parameter, whereas the platelet count was only of prognostic significance within the first 6 months from diagnosis and the presence of osteomyelosclerosis emerged as a favourable parameter at 3 and 5 years. Based upon the above parameters and spleen size, a prognostic scoring system was designed which categorized the patients into three prognostic groups with highly different survival times (low risk group = 69 months; intermediate risk group = 33 months; high risk group = 4 months).

摘要

相似文献

1
Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
Eur J Haematol. 1990 Mar;44(3):172-8. doi: 10.1111/j.1600-0609.1990.tb00372.x.
2
Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis.在特发性骨髓纤维化患者初诊时识别“短期存活”和“长期存活”患者。
Br J Haematol. 1997 Jun;97(3):635-40. doi: 10.1046/j.1365-2141.1997.782714.x.
3
Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.骨髓网硬蛋白纤维在原发性骨髓纤维化中的预后意义:评分系统中临床病理参数的评估
Haematologia (Budap). 1994;26(2):75-86.
4
Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.慢性特发性骨髓纤维化:骨髓纤维化及临床参数对122例处于纤维化前期和纤维化期患者无事件生存期的预后影响。一项采用RECPAM方法识别不同预后亚组的回顾性研究。
Ann Hematol. 2003 Oct;82(10):605-11. doi: 10.1007/s00277-003-0719-9. Epub 2003 Aug 28.
5
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.
Leuk Lymphoma. 2006 Mar;47(3):441-50. doi: 10.1080/10428190500353315.
6
Prognostic factors in myelofibrosis.骨髓纤维化的预后因素。
Pathology. 1982 Oct;14(4):455-61. doi: 10.3109/00313028209092127.
7
Idiopathic myelofibrosis--an update with particular reference to clinical aspects and prognosis.原发性骨髓纤维化——特别涉及临床方面和预后的最新进展
Int J Clin Lab Res. 1993;23(3):124-38. doi: 10.1007/BF02592297.
8
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.基于骨髓纤维化研究与治疗国际工作组的一项研究的原发性骨髓纤维化新预后评分系统。
Blood. 2009 Mar 26;113(13):2895-901. doi: 10.1182/blood-2008-07-170449. Epub 2008 Nov 6.
9
Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases.原发性骨髓纤维化的细胞遗传学异常及其预后意义:106例研究
Br J Haematol. 1997 Jul;98(1):96-102. doi: 10.1046/j.1365-2141.1997.1722990.x.
10
Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Anticancer Res. 1989 Mar-Apr;9(2):429-35.

引用本文的文献

1
Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib-A Real-Life Longitudinal Study.芦可替尼治疗骨髓纤维化患者的疗效与生存情况——一项真实世界纵向研究
Cancers (Basel). 2023 Oct 20;15(20):5085. doi: 10.3390/cancers15205085.
2
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.
3
Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.
Int J Hematol. 2001 Feb;73(2):194-8. doi: 10.1007/BF02981937.
4
Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
Ann Hematol. 1994 Apr;68(4):205-12. doi: 10.1007/BF01834368.